San Diego, California--(Newsfile Corp. - October 10, 2023) - Ainnocence, a leading AI innovator in biotechnology launched a groundbreaking AI-enabled platform for antibody affinity maturation and de ...

Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...